Check up: Sometimes no news is good news
Health & Biotech
Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 134-odd small cap health stocks and of those which were trading on Wednesday, 71 were in positive territory over the last fortnight, 11 were flat and 52 saw their share prices fall.
Code | Name | Price $ (June 10) | 2 week return % | 1 year return % | Market cap |
---|---|---|---|---|---|
CTE | CRYOSITE LTD | 0.185 | 118 | 340 | $8,669,019 |
ESE | ESENSE-LAB LTD-CDI | 0.017 | 80 | -10 | $3,421,385 |
DXB | DIMERIX LTD | 0.44 | 59 | 444 | $78,056,488 |
SOM | SOMNOMED LTD | 1.5 | 49 | 5 | $124,516,056 |
ACW | ACTINOGEN MEDICAL LTD | 0.026 | 39 | 150 | $27,905,784 |
NTI | NEUROTECH INTERNATIONAL LTD | 0.008 | 33 | -65 | $1,721,725 |
ZLD | ZELIRA THERAPEUTICS LTD | 0.063 | 31 | 54 | $61,269,288 |
PTX | PRESCIENT THERAPEUTICS LTD | 0.064 | 31 | 56 | $25,232,680 |
ACR | ACRUX LTD | 0.17 | 30 | -10 | $29,494,240 |
OVN | OVENTUS MEDICAL LTD | 0.34 | 29 | 53 | $53,086,748 |
AVE | AVECHO BIOTECHNOLOGY LTD | 0.009 | 29 | 200 | $14,377,117 |
1ST | 1ST GROUP LTD | 0.035 | 28 | -20 | $15,710,825 |
SCU | STEMCELL UNITED LTD | 0.014 | 27 | -18 | $8,982,517 |
PIQ | PROTEOMICS INTERNATIONAL LAB | 0.515 | 26 | 48 | $42,265,204 |
SDX | SIENNA CANCER DIAGNOSTICS LT | 0.076 | 26 | 39 | $30,820,362 |
GLH | GLOBAL HEALTH LTD | 0.175 | 25 | 44 | $7,367,206 |
OSL | ONCOSIL MEDICAL LTD | 0.13 | 24 | 121 | $108,173,120 |
BNO | BIONOMICS LTD | 0.071 | 23 | -16 | $36,493,952 |
ZNO | ZOONO GROUP LTD | 2.28 | 22 | 1982 | $374,673,088 |
OPT | OPTHEA LTD | 3.49 | 20 | 394 | $904,370,112 |
ALC | ALCIDION GROUP LTD | 0.18 | 20 | 44 | $178,324,928 |
PAA | PHARMAUST LTD | 0.115 | 20 | 211 | $34,732,420 |
PAR | PARADIGM BIOPHARMACEUTICALS | 3.25 | 20 | 121 | $710,169,472 |
RSH | RESPIRI LTD | 0.084 | 18 | -38 | $54,097,472 |
RNO | RHINOMED LTD | 0.084 | 18 | -60 | $14,467,114 |
SVA | SIMAVITA LTD-CDI | 0.023 | 15 | 35 | $12,966,897 |
BD1 | BARD1 LIFE SCIENCES LTD | 0.03 | 15 | 36 | $42,382,736 |
PSQ | PACIFIC SMILES GROUP LTD | 1.6 | 14 | 35 | $245,624,880 |
IBX | IMAGION BIOSYSTEMS LTD | 0.032 | 14 | 49 | $24,370,564 |
GSS | GENETIC SIGNATURES LTD | 2.24 | 14 | 105 | $319,448,640 |
NC6 | NANOLLOSE LTD | 0.04 | 14 | -28 | $4,230,000 |
M7T | MACH7 TECHNOLOGIES LTD | 0.79 | 14 | 119 | $144,577,216 |
JHL | JAYEX HEALTHCARE LTD | 0.025 | 14 | -49 | $4,409,076 |
ICS | ICSGLOBAL LTD | 2.05 | 14 | 115 | $21,738,238 |
CDX | CARDIEX LTD | 0.025 | 13 | -19 | $19,583,442 |
IMU | IMUGENE LTD | 0.036 | 13 | 140 | $159,334,944 |
SUD | SUDA PHARMACEUTICALS LTD | 0.042 | 11 | -71 | $5,974,685 |
VBS | VECTUS BIOSYSTEMS LTD | 0.72 | 10 | 106 | $17,031,468 |
IMM | IMMUTEP LTD | 0.175 | 9 | -32 | $85,335,416 |
AMT | ALLEGRA ORTHOPAEDICS LTD | 0.12 | 9 | 20 | $11,947,086 |
ANR | ANATARA LIFESCIENCES LTD | 0.19 | 9 | -42 | $9,472,674 |
BXN | BIOXYNE LTD | 0.013 | 8 | -28 | $8,321,890 |
AHX | APIAM ANIMAL HEALTH LTD | 0.47 | 8 | 16 | $56,549,612 |
PAB | PATRYS LTD | 0.015 | 8 | -46 | $15,016,265 |
OCC | ORTHOCELL LTD | 0.355 | 8 | -12 | $65,568,048 |
THC | THC GLOBAL GROUP LTD | 0.395 | 7 | -7 | $59,141,536 |
MVF | MONASH IVF GROUP LTD | 0.595 | 6 | -49 | $233,780,896 |
VLS | VITA LIFE SCIENCES LTD | 0.57 | 6 | -16 | $30,827,088 |
CYC | CYCLOPHARM LTD | 1.495 | 5 | 3 | $118,492,136 |
ELX | ELLEX MEDICAL LASERS LTD | 0.52 | 5 | -6 | $75,390,600 |
UCM | USCOM LTD | 0.235 | 5 | 45 | $33,711,376 |
JHC | JAPARA HEALTHCARE LTD | 0.575 | 5 | -50 | $155,003,456 |
AZV | AZURE HEALTHCARE LTD | 0.07 | 4 | -10 | $19,893,226 |
AVH | AVITA MEDICAL LTD | 0.4825 | 4 | 43 | $1,039,714,432 |
ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.048 | 4 | -80 | $8,487,363 |
LBT | LBT INNOVATIONS LTD | 0.165 | 3 | 14 | $38,864,064 |
NYR | NYRADA INC-CDI | 0.17 | 3 | -15 | $18,595,232 |
RAP | RESAPP HEALTH LTD | 0.17 | 3 | 3 | $128,645,912 |
NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.19 | 3 | 29 | $14,109,225 |
ONT | 1300 SMILES LTD | 5.45 | 3 | -12 | $129,047,192 |
MDR | MEDADVISOR LTD | 0.615 | 3 | 56 | $150,479,120 |
HLA | HEALTHIA LTD | 1.055 | 2 | 23 | $66,501,560 |
OIL | OPTISCAN IMAGING LTD | 0.044 | 2 | -6 | $21,022,268 |
PYC | PYC THERAPEUTICS LTD | 0.09 | 2 | 246 | $263,828,512 |
RHY | RHYTHM BIOSCIENCES LTD | 0.095 | 2 | -42 | $9,571,250 |
S66 | STAR COMBO PHARMA LTD | 0.485 | 2 | -26 | $65,095,968 |
BWX | BWX LTD | 3.88 | 2 | 131 | $480,847,072 |
CGS | COGSTATE LTD | 0.32 | 2 | 56 | $55,297,180 |
AT1 | ATOMO DIAGNOSTICS LTD | 0.32 | 2 | 60 | $185,155,680 |
CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.092 | 1 | -39 | $8,846,875 |
RCE | RECCE PHARMACEUTICALS LTD | 0.715 | 1 | 264 | $104,094,920 |
TLX | TELIX PHARMACEUTICALS LTD | 1.425 | 0 | 35 | $359,048,672 |
IVX | INVION LTD | 0.008 | 0 | -47 | $44,004,852 |
MEB | MEDIBIO LTD | 0.007 | 0 | -40 | $6,068,780 |
AC8 | AUSCANN GROUP HOLDINGS LTD | 0.17 | 0 | -53 | $53,898,052 |
CMP | COMPUMEDICS LTD | 0.49 | 0 | -2 | $87,695,656 |
LCT | LIVING CELL TECHNOLOGIES LTD | 0.013 | 0 | -58 | $7,428,733 |
NEU | NEUREN PHARMACEUTICALS LTD | 1.63 | 0 | 42 | $173,325,632 |
LSH | LIFESPOT HEALTH LTD | 0.03 | 0 | -58 | $2,630,920 |
VTI | VISIONEERING TECH-CDI | 0.017 | 0 | -64 | $13,291,766 |
PAL | PALLA PHARMA LTD | 0.81 | 0 | -26 | $100,758,384 |
PNV | POLYNOVO LTD | 2.7 | 0 | 113 | $1,778,326,784 |
CYP | CYNATA THERAPEUTICS LTD | 0.665 | -1 | -47 | $77,738,168 |
OSX | OSTEOPORE LTD | 0.485 | -1 | 143 | $49,602,944 |
IMC | IMMURON LTD | 0.36 | -1 | -39 | $14,709,128 |
KZA | KAZIA THERAPEUTICS LTD | 0.43 | -1 | 4 | $38,785,332 |
SDI | SDI LTD | 0.74 | -2 | -14 | $87,960,496 |
CAJ | CAPITOL HEALTH LTD | 0.22 | -2 | 2 | $224,971,376 |
RHT | RESONANCE HEALTH LTD | 0.185 | -3 | 68 | $82,098,176 |
TD1 | TALI DIGITAL LTD | 0.03 | -3 | 76 | $22,479,156 |
MX1 | MICRO-X LTD | 0.14 | -3 | -43 | $50,003,496 |
ATX | AMPLIA THERAPEUTICS LTD | 0.135 | -4 | 23 | $8,972,530 |
ADR | ADHERIUM LTD | 0.027 | -4 | 17 | $16,235,240 |
APH | AUSTRALIAN PRIMARY HEMP LTD | 0.125 | -4 | -43 | $8,719,392 |
NXS | NEXT SCIENCE LTD | 1.495 | -4 | -53 | $269,536,064 |
AGH | ALTHEA GROUP HOLDINGS LTD | 0.365 | -4 | -44 | $86,324,704 |
MXC | MGC PHARMACEUTICALS LTD | 0.024 | -4 | -54 | $37,814,696 |
ADO | ANTEOTECH LTD | 0.022 | -4 | 73 | $36,169,844 |
PBP | PROBIOTEC LTD | 1.86 | -5 | 23 | $139,088,704 |
MDC | MEDLAB CLINICAL LTD | 0.205 | -5 | -46 | $47,810,472 |
RAC | RACE ONCOLOGY LTD | 0.305 | -5 | 408 | $35,255,700 |
1AD | ADALTA LTD | 0.1 | -5 | -48 | $13,279,595 |
VHT | VOLPARA HEALTH TECHNOLOGIES | 1.37 | -5 | -25 | $347,055,296 |
IHL | IMPRESSION HEALTHCARE LTD | 0.052 | -5 | 121 | $38,688,840 |
BIT | BIOTRON LTD | 0.088 | -5 | 29 | $61,770,080 |
PXS | PHARMAXIS LTD | 0.086 | -5 | -66 | $33,991,432 |
RGS | REGENEUS LTD | 0.071 | -7 | -24 | $19,725,574 |
UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.21 | -7 | 5 | $37,266,468 |
MVP | MEDICAL DEVELOPMENTS INTERNA | 7.65 | -7 | 47 | $504,644,640 |
SKN | SKIN ELEMENTS LTD | 0.08 | -7 | 82 | $25,411,448 |
MMJ | MMJ GROUP HOLDINGS LTD | 0.125 | -8 | -51 | $27,594,478 |
IDT | IDT AUSTRALIA LTD | 0.17 | -8 | 0 | $40,683,216 |
CAN | CANN GROUP LTD | 1.08 | -9 | -47 | $158,249,440 |
BOT | BOTANIX PHARMACEUTICALS LTD | 0.047 | -9 | -52 | $46,689,508 |
PGC | PARAGON CARE LTD | 0.15 | -12 | -65 | $50,682,792 |
MEM | MEMPHASYS LTD | 0.058 | -12 | 152 | $43,730,484 |
FFC | FARMAFORCE LTD | 0.07 | -13 | -39 | $9,013,969 |
OSP | OSPREY MEDICAL INC-CDI | 0.014 | -13 | -87 | $17,997,570 |
IPD | IMPEDIMED LTD | 0.07 | -13 | -33 | $74,125,600 |
FTT | FACTOR THERAPEUTICS LTD | 0.003 | -14 | -40 | $3,128,507 |
GMV | G MEDICAL INNOVATION HOLDING | 0.06 | -14 | -74 | $39,163,408 |
HCT | HOLISTA COLLTECH LTD | 0.145 | -15 | 116 | $39,925,616 |
ANP | ANTISENSE THERAPEUTICS LTD | 0.067 | -15 | 31 | $30,793,472 |
ICR | INTELICARE HOLDINGS LTD | 0.4 | -18 | 100 | $28,795,384 |
CDY | CELLMID LTD | 0.185 | -18 | -5 | $22,329,762 |
NOX | NOXOPHARM LTD | 0.185 | -18 | -62 | $31,523,232 |
BPH | BPH ENERGY LTD | 0.008 | -20 | -20 | $2,985,795 |
ATH | ALTERITY THERAPEUTICS LTD | 0.016 | -20 | -53 | $16,597,729 |
PCK | PAINCHEK LTD | 0.155 | -22 | -17 | $150,150,752 |
EXL | ELIXINOL GLOBAL LTD | 0.225 | -22 | -93 | $43,388,340 |
CPH | CRESO PHARMA LTD | 0.056 | -25 | -91 | $14,236,152 |
GTG | GENETIC TECHNOLOGIES LTD | 0.005 | -29 | -23 | $37,568,900 |
ALT | ANALYTICA LTD | 0.003 | -33 | -60 | $7,039,225 |
DVL | DORSAVI LTD | 0.015 | -35 | -76 | $3,471,413 |
A rising tide lifts the strangest of boats and, this week, not the ones with the biggest news.
Cryosite (ASX:CTE), a company that cold-stores biological samples, saw a share price surge over the last two weeks.
On June 28 there was a surge of buying, with over 700,000 shares acquired.
Since September chairman Andrew Kroger has been the only director, and only substantial shareholder trading in the stock. He now has a 40.31 per cent interest, as of the last notice in April.
Aside from that, there’s few other clues as to why this stock rose 118 per cent in the last fortnight.
Of the two most highly anticipated pieces of news, one delivered a disappointment and the other didn’t deliver at all — or at least, not the news investors expected.
The other piece of news was eye biotech Opthea (ASX:OPT), which disappointed investors with clinical trial results labelled by one analyst as “underwhelming”.
Its drug OPT-302 had been studied in a clinical trial as a treatment for diabetic macular edema (DME).
It met primary and secondary endpoints, but the results did not show a significant difference to the standard of care.
The stock, which has risen strongly over the last two weeks in anticipation of a repeat of a spectacular trial last year into wet-age related macular degeneration, dropped by 8 per cent in the hours after the news was announced.
Dimerix (ASX:DXB) shares surged not after it released data from the two clinical trials it’s running, but because its fibrosis drug has been chosen for a global study on COVID-19.
At one point the stock was up over 120 per cent.
Sleep apnoea company Somnomed (ASX:SOM) was having a — very cautious — celebration last week after sales slipped not nearly as badly following the COVID-19 closures.
Sales of its mouthguard, fitted by dentists, that helps combat snoring, tooth grinding, and sleep apnoea, were down 61 per cent.
Somnomed CEO Neil Verdal-Austin said they were “cautiously optimistic” as countries in Europe, North America and Asia re-open.
The timely $15.5m capital raising in March combined with pay cuts across the board and a knife taken to costs means the company is in a hopeful position.
And Neurotech International (ASX:NTI) was called out by the ASX for its rapid price rise.
It’s rare for a company to admit, but it did in fact know something the market didn’t — but clearly some people did, and traded on it.
“The company was aware of information concerning it that had not been announced to the market,” Neurotech revealed.
“The information related to negotiation of a proposed heads of agreement for a strategic collaboration in respect of rights under a distribution agreement to market and sell TGA approved IgM, IgG Antibody COVID-19 testing kits in Australia, New Zealand (exclusive) and all other countries (non-exclusive) other than China.”
Two months ago that would have sent the stock stratospheric. Today? A mere 33 per cent. And that was from a starting point of 0.8c when a couple of grand can move the market.